Robert M. VanHimbergen, Executive Vice President and CFO of Elanco Animal Health Inc, filed a statement of changes in beneficial ownership on November 17, 2026, disclosing an acquisition of deferred stock units dated November 13, 2026.

Key Highlights

  • Reporting person: Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc (NYSE:ELAN)
  • Transaction date: November 13, 2026, with the filing submitted November 17, 2026
  • Securities acquired: 7.357 Deferred Stock Units (transaction code A) at a price of $26.78 per unit
  • Post-transaction holdings: 191.8191 Deferred Stock Units held directly following the reported transaction
  • Settlement terms: Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent, settling upon termination of employment or during a specified future year under the Executive Deferral and Stock Match Plan
  • Filing basis: Filed by one reporting person; signed by Amy C. Seidel as Attorney-in-Fact for Robert M. VanHimbergen

CFO Deferred Stock Unit Acquisition Under Elanco Executive Deferral Plan

According to the filing, VanHimbergen acquired 7.357 Deferred Stock Units in Elanco Animal Health Inc on November 13, 2026, at a price of $26.78. The transaction was recorded as an acquisition (code A) in Table II of the form, which covers derivative securities. Elanco Animal Health Inc is an animal health company listed on the NYSE under the ticker ELAN, with its principal offices located at 450 Elanco Circle, Indianapolis, Indiana 46221.

The filing notes that each deferred stock unit "represents the right to receive one share of Company common stock or the cash equivalent." Settlement occurs "in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan," according to the explanatory footnotes in the filing. Following this transaction, VanHimbergen directly holds 191.8191 Deferred Stock Units in total. No non-derivative securities transactions were reported in Table I of this filing.

What Was Disclosed

The filing disclosed that Elanco Animal Health Inc's EVP and CFO, Robert M. VanHimbergen, acquired 7.357 Deferred Stock Units at $26.78 on November 13, 2026, bringing his total direct holdings of such units to 191.8191, under the company's Executive Deferral and Stock Match Plan.